[
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.35. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 7. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:23 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. Tobacco smoker: non-smoker  Exercise hrs per week:2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 16, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.89 sec. 9-hole peg non-dominant:36.23 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2020. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:24 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:logistic issues to obtain the DMT. New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.78. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 2. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.42. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:nmo. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on August 24, 2021. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Coffee cups per week: 21. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:cis. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on May 01, 2019. Comments on DMT: Avonex 07\/01\/2013 until May 2019. The 25-foot walk done. 25-foot walk test time was 3.25 sec. SDMT done. SDMT numerator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2007. Comments on DMT: Avonex(2006-2007). MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on February 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 99. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 15. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.9 sec. 9-hole peg non-dominant:27.7 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2011. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.94 sec. 9-hole peg non-dominant:16.84 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.07. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on September 27, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:3.41. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on December 01, 2017. Comments on DMT: Rebif. Vit D at visit: 25.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 13, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.02 sec. 9-hole peg non-dominant:18.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2017. Comments on DMT: Avonex, Rebif, Gilenya. Tobacco smoker: current  Tobacco type: cigarette or cigar. Exercise hrs per week:5. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. Comments on DMT: Endoxan (Cyclophosphamide); Imuran (Azathioprine); Mitoxantrone; Other; Rebif; Solumedrol. SDMT done. SDMT numerator: 18. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:69 sec. 9-hole peg non-dominant:26.3 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on July 01, 2020. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.5 sec. 9-hole peg non-dominant:21 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mavenclad- Cladribine. The patient is in NEDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2017. Comments on DMT: Cellcept. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:18 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on January 16, 2015. Comments on DMT: betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 28. The 25-foot walk done. 25-foot walk test time was 5.7 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31.76 sec. 9-hole peg non-dominant:31.78 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 20, 2003. The 25-foot walk done. 25-foot walk test time was 5.18 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.3 sec. 9-hole peg non-dominant:21.48 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Gilenya until October 2017. Tobacco smoker: non-smoker  EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on April 05, 2012. Comments on DMT:  rebif and Atacicept. The 25-foot walk done. 25-foot walk test time was 13.25 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2017. Tobacco smoker: non-smoker  EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:pregnancy plans. The patient is in NEDA. Will the patient be in NEDA or EDA after 30 months?",
        "output":"After 30 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on July 01, 2018. Comments on DMT: Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.4 sec. 9-hole peg non-dominant:20 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2012. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:25 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. More information on co-morbidity:herpes zoster ophthalmicus. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:endoxan- cyclophosphamide on May 02, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 34.17 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:33.13 sec. 9-hole peg non-dominant:35.46 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:5. OCBs in second CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2014. Comments on DMT: Avonex; Betaferon; Gilenya. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.4 sec. 9-hole peg non-dominant:22.9 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on February 01, 2019. Comments on DMT: Betaferon, Gilenya. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.2 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation focal spasms. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25 sec. 9-hole peg non-dominant:25.68 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mavenclad- cladribine on December 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: June 01, 2020. Received Gadolinium for Cervical spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:15.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.77. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on May 17, 2021. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:papillary urothelial cancer . Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2011. Comments on DMT: Avonex Jan 2010-June 2010. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: lightly. Vit D at visit: 5708.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 12. SDMT denominator: 16. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.57 sec. 9-hole peg non-dominant:24.88 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on June 18, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 16, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 6 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.15 sec. 9-hole peg non-dominant:30.25 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.92. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:nmo. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on September 01, 2014. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 06, 2017. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.8 sec. 9-hole peg non-dominant:17.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2019. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 99. Cervical spine MRI date: October 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 999. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 8. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.5 sec. 9-hole peg non-dominant:15.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:81.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Name of co-morbidity:Trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Cellulitis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteoporosis. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:relpasing-progressive ms. Total relapses until visit: 7. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2002. Comments on DMT: avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 114 months?",
        "output":"After 114 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.55. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on September 01, 2016. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2004. Comments on DMT: Avonex (2004), Betaferon (2004). Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 14.95 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.2 sec. 9-hole peg non-dominant:36.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:change in diagnosis. New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Hidradenitis Suppurutiva. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2014. Comments on DMT:  - Avonex -  Tysabri, . The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 28.99 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 30. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right.  9-hole peg dominant:43.28 sec. 9-hole peg non-dominant:75.17 sec. EDSS:8- essentially restricted to bed or chair or perambulated in wheelchair but out of bed most of day; retains many self-care functions; generally has effective use of arms. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: None . Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 99. Cervical spine MRI date: May 01, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.68 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.2 sec. 9-hole peg non-dominant:18.1 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2002. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.9 sec. 9-hole peg non-dominant:19.9 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 2. The 25-foot walk done. 25-foot walk test time was 3.92 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 15, 2014. Comments on DMT: avonex, betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.32 sec. 9-hole peg non-dominant:23.41 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 32. DMT taken. Current DMT:tysabri- natalizumab on August 01, 2016. Comments on DMT: Avonex - Rebif - Gilenya. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 24 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29 sec. 9-hole peg non-dominant:36 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2016. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2011. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 2-3 HB\/week. Vit D at visit: 57.2. The 25-foot walk done. 25-foot walk test time was 3.59 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.4 sec. 9-hole peg non-dominant:26.28 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. Comments on DMT: Betaferon, Gilenya, Tecfidera, Rebif, Tysabri. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5.3 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.8 sec. 9-hole peg non-dominant:23.2 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2013. Comments on DMT: Betaferon, Gilenya. Tobacco smoker: non-smoker  Exercise hrs per week:5. Vit D at visit: 88.7. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.45 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.12 sec. 9-hole peg non-dominant:17.47 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:22.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 01, 2020. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:22.35 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.77. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on April 01, 2022. Tobacco smoker: ex-smoker  Exercise hrs per week:8. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.24 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:cis. DMT taken. Current DMT:aubagio- teriflunomide on April 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 26, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:18.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hashimoto thyroiditis. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. There were new relapses since the previous visit. Tobacco smoker: non-smoker  MRI of brain or spine done. Cervical spine MRI date: September 15, 2021. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.2 sec. 9-hole peg non-dominant:19.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Brain Tumor. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on July 01, 2018. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2013. Comments on DMT: Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: December 20, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Remarks about MRI: Increase in the size of a right frontal lesion with evidence of enhancement consistent with active demyelination. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 19. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.9 sec. 9-hole peg non-dominant:22.33 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:48.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:completely recovered from illness. Visit diagnosis:cis. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Blood and lymphatic disorders. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 14.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: November 12, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.85 sec. 9-hole peg non-dominant:17.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness, brainstem. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:breast cancer. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on September 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: July 01, 2021. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.33. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2017. Tobacco smoker: non-smoker  Coffee cups per week: 7. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: April 21, 2022. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:21.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 5.78 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.04 sec. 9-hole peg non-dominant:17.96 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:90.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Hysterectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:bilateral cataract surgery. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:PTCA stenting. Outcome:completely recovered from illness. Name of co-morbidity:Posterior capsular opasification of lens bilaterally. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:chronic nausea. Outcome:ongoing illness. Visit diagnosis:spms. Several relapses until this visit. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 16.34 sec. SDMT done. SDMT numerator: 25. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:36 sec. 9-hole peg non-dominant:29 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:imuran-azathioprine on November 12, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 06, 2019. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 36 months?",
        "output":"After 36 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.75. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:hashimoto thyroiditis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2014. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:17 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2006. Comments on DMT: imuran. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 45 months?",
        "output":"After 45 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.3. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 4.41 sec. SDMT done. SDMT numerator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.61 sec. 9-hole peg non-dominant:21.33 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.75. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on January 17, 2019. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Herpse Zoster. More information on co-morbidity:herpes zoster ophthalmicus. Outcome:completely recovered from illness. Visit diagnosis:spms. Several relapses until this visit. Comments on DMT: Avonex, Endoxan (Cyclophosphamide), Rebif. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 37 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:36.1 sec. 9-hole peg non-dominant:31.1 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2013. Comments on DMT: Cellcept July 2012-Oct 2012. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 40.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 30, 2013. The 25-foot walk done. 25-foot walk test time was 5.4 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31 sec. 9-hole peg non-dominant:27 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.45 sec. 9-hole peg non-dominant:20 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on October 22, 2018. Comments on DMT: rebif, tecfidera. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 09, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:14.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.81. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Name of co-morbidity:Asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on July 01, 2018. Comments on DMT: Aubagio. Tobacco smoker: non-smoker  Vit D at visit: 82.0. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.44 sec. 9-hole peg non-dominant:22.42 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Anti phospholipid syndrome. Outcome:ongoing illness. Name of co-morbidity:Familial Mediteranean Fever. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2013. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.1 sec. 9-hole peg non-dominant:35.78 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on May 01, 2013. Comments on DMT: Cellcept July 2012-Oct 2012. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 01, 2014. The 25-foot walk done. 25-foot walk test time was 5.81 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.52 sec. 9-hole peg non-dominant:26.57 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on October 01, 2019. Vit D at visit: 60.3. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:18 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:7. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on April 01, 2017. Comments on DMT: Rebif Oct 2000-July 2014, Tysabri Aug 2014-Feb 2017. Tobacco smoker: non-smoker  Coffee cups per week: 21. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 11, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 8.16 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.58 sec. 9-hole peg non-dominant:43.87 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT: tysabri- natalizumab. Comments on DMT: Avonex - Rebif - Gilenya. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 117.7 sec. SDMT done. SDMT numerator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.1 sec. 9-hole peg non-dominant:30.87 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2011. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.37 sec. 9-hole peg non-dominant:16.22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 19 sec. SDMT done. SDMT numerator: 26. SDMT denominator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:30 sec. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:negative. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: August 04, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 29 months?",
        "output":"After 29 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:aubagio- teriflunomide on September 01, 2018. The 25-foot walk done. 25-foot walk test time was 5.81 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.01 sec. 9-hole peg non-dominant:20.59 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 02, 2018. Comments on DMT: Avonex; Gilenya; Tysabri. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: March 11, 2019. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.4 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.3 sec. 9-hole peg non-dominant:25.59 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis, cerebellar. OCBs in CSF:positive. IgG index in CSF:1.13. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 6. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 09, 2019. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 24, 2020. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:5. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on September 15, 2014. Comments on DMT: Betaferon June 2006 to August 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: October 19, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.55 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.47 sec. 9-hole peg non-dominant:22.46 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:10. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 11. The 25-foot walk done. Assistance required for 25-foot walk test: Rollator. 25-foot walk test time was 18.4 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.73 sec. 9-hole peg non-dominant:18.35 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:copaxone- glatiramer acetate on January 01, 2007. Comments on DMT: Avonex. The patient is in EDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Blood and lymphatic disorders. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2016. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 14. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: February 13, 2018. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:18.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on December 01, 2018. Comments on DMT: Rebif Aubagio Gilenya. Vit D at visit: 27.2. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: November 17, 2020. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:20 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. Total relapses until visit: 4. Comments on DMT: Tysabri, Rebif. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 27, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 16 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.25. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 11. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: avonex, atacicept, rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: hubble bubble. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:18 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 01, 2013. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Cervical spine MRI date: August 01, 2021. Received Gadolinium for Cervical spine MRI. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. Comments on DMT: Tysabri, Betaferon, Aubagio, Cyclophosphamide. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 14 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:33 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Uveitis. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Behcet Disease. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: imuran-azathioprine. Comments on DMT: Betaferon. The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2012. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 01, 2014. The 25-foot walk done. 25-foot walk test time was 8.92 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.63 sec. 9-hole peg non-dominant:23.42 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:23.1 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. Cervical spine MRI: T2 lesion, unknown enhancement (MRI without gad). The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.3 sec. 9-hole peg non-dominant:28.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Anterior Uveitis. Name of co-morbidity:Migraine. Name of co-morbidity:Depression. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on April 01, 2011. Comments on DMT: Rebid Avonex. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:17 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:69.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Diabetes mellitus type 1. More information on co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 8. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on May 09, 2014. Comments on DMT: Betaferon, imuran, mabthera, endoxan. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 15, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 28.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:37.4 sec. 9-hole peg non-dominant:28.8 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:autoimmune alopecia universalis. Outcome:ongoing illness. Name of co-morbidity:congenital vision loss in right eye. Outcome:ongoing illness. Name of co-morbidity:nail dystrophy. Outcome:ongoing illness. Name of co-morbidity:hereditary senosry motor demyelinating neuropathy. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on May 01, 2017. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 07, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.42. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Right breast cancer. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:right shoulder tendinitis. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on December 07, 2017. Comments on DMT: avonex. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 28. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: April 05, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:25.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation brainstem. Has experienced progressive symptoms since onset. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:OCD. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 7.5 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:55 sec. 9-hole peg non-dominant:53 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.84. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.92. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2015. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 15, 2016. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 44 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:122 sec. 9-hole peg non-dominant:60 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.75. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 09, 2013. Comments on DMT: rebif, avonex, imran. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.7 sec. 9-hole peg non-dominant:16.22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.47. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 4. Cervical spine MRI date: October 07, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T1 lesions, gad-enhancing. Total T1 Gad-enhancing lesions in Thoracic spine: 4. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.1 sec. 9-hole peg non-dominant:22.5 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:1.89. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 1. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:ocrevus - ocrelizumab on May 01, 2021. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: November 01, 2021. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:23.5 sec. 9-hole peg non-dominant:19.96 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on November 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 01, 2021. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30 sec. 9-hole peg non-dominant:20.8 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:25.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2012. Comments on DMT: Betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 28. Vit D at visit: 46.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.25 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.4 sec. 9-hole peg non-dominant:19.26 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on May 28, 2018. Comments on DMT: Avonex. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: November 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.01 sec. 9-hole peg non-dominant:22.94 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2014. Comments on DMT: Rebif, REFLEX. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 3HB\/wk. The 25-foot walk done. 25-foot walk test time was 8.4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.34 sec. 9-hole peg non-dominant:20.29 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:74.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hashimoto thyroiditis. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:arthritis. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:decompression of spondylolisthesis. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:right tronchanteric bursitis. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:total hip replacement. Outcome:completely recovered from illness. Visit diagnosis:cis. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2007. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: No lesions. Cervical spine MRI date: February 03, 2010. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The patient is in EDA. Will the patient be in NEDA or EDA after 94 months?",
        "output":"After 94 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.07. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anxiety. More information on co-morbidity:GAD, Social anxiety. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 23.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:25.2 sec. 9-hole peg non-dominant:24.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:6. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2012. Comments on DMT: Betaferon, Avonex, Atoricept, Rebif. MRI of brain or spine done. Cervical spine MRI date: June 16, 2014. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.7 sec. 9-hole peg non-dominant:46.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:pregnancy plans. New DMT:Solumedrol- IV Methylprednisolone. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Comments on DMT: Avonex. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.3 sec. 9-hole peg non-dominant:16 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mavenclad- Cladribine. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:86.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation myelitis. Number of attacks until the first visit:3. Name of co-morbidity:Diffuse cystic mastopathy s\/p subtotal mastectomy. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Pneumonitis. Outcome:completely recovered from illness. Name of co-morbidity:Sepsis. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:hemorrhage. Outcome:death due to illness. Visit diagnosis:spms. Total relapses until visit: 3. Comments on DMT: Mitoxantrone  - Avonex - Mabthera  - Betaferon . SDMT done. SDMT numerator: 5. SDMT denominator: 5. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:48.38 sec. 9-hole peg non-dominant:80.24 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:knee trauma. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Cinnovex until 2014. Tobacco smoker: non-smoker  Vit D at visit: 4.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: November 27, 2017. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 5. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 32. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.5 sec. 9-hole peg non-dominant:38.9 sec. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Solumedrol- IV Methylprednisolone. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 3.86 sec. SDMT done. SDMT numerator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:21.93 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Name of co-morbidity:EPILEPSY. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2009. The 25-foot walk done. SDMT done. SDMT numerator: 32. SDMT denominator: 35. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:26.21 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:78.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis, brainstem. Number of attacks until the first visit:2. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:right hip fracture. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 01, 2011. Comments on DMT: Avonex 2006, Rebif 2007, Mitoxantrone June 2011. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 ppd. Coffee cups per week: 28. Vit D at visit: 28.3. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 44.44 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.41 sec. 9-hole peg non-dominant:24.31 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2014. Comments on DMT: Imuran (started on 8\/8\/2014). MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.3 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.4 sec. 9-hole peg non-dominant:24.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.5. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:progressive myelopathy. Several relapses until this visit. SDMT done. SDMT numerator: 15. SDMT denominator: 17. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:58.78 sec. 9-hole peg non-dominant:53.1 sec. EDSS:7.5- unable to take more than a few steps; restricted to wheelchair; may need some help in transferring and in wheeling self. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.48. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. DMT taken. Current DMT:ocrevus - ocrelizumab on April 21, 2020. Comments on DMT: aubagio. Tobacco smoker: non-smoker  The 25-foot walk done. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.19 sec. 9-hole peg non-dominant:17.54 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, incidental mri findings. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.91. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 27.1. MRI of brain or spine done. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.81 sec. 9-hole peg non-dominant:18.85 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Visit diagnosis:rrms. Total relapses until visit: 10. DMT taken. Current DMT:mabthera- rituximab on November 01, 2018. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 7 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.45 sec. 9-hole peg non-dominant:22.48 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Oral Candidiasis. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on May 29, 2017. Comments on DMT: Betaferon. Vit D at visit: 52.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: April 01, 2017. The 25-foot walk done. 25-foot walk test time was 4.15 sec. SDMT done. SDMT numerator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.52 sec. 9-hole peg non-dominant:17.91 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2018. Tobacco smoker: non-smoker  Vit D at visit: 66.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Cervical spine MRI date: February 21, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Remarks about MRI: A new enhancing lesion in the left posterior temporal region. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.57 sec. 9-hole peg non-dominant:23.78 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Visit diagnosis:nmo. DMT taken. Current DMT:imuran-azathioprine on January 01, 2013. MRI of brain or spine done. Cervical spine MRI date: September 08, 2015. The 25-foot walk done. 25-foot walk test time was 4.21 sec. SDMT done. SDMT numerator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.64 sec. 9-hole peg non-dominant:19.42 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 28 months?",
        "output":"After 28 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Gilenya Jan 2015 until 10\/Dec\/2015. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 90. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.23 sec. 9-hole peg non-dominant:15.95 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. Tobacco smoker: non-smoker  Vit D at visit: 26.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Cervical spine MRI date: January 05, 2015. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 6.11 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.46 sec. 9-hole peg non-dominant:25.13 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.06. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on June 01, 2015. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: January 26, 2016. Evidence of LETM. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.26 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.82 sec. 9-hole peg non-dominant:29.49 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2018. Vit D at visit: 48.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:19.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on June 23, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 17, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:19.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2014. Comments on DMT: Rebif + REFLEX trial. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: occasional. Vit D at visit: 72.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 01, 2014. The 25-foot walk done. 25-foot walk test time was 4.33 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.54 sec. 9-hole peg non-dominant:22.42 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:negative. IgG index in CSF:1.45. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on August 01, 2017. Comments on DMT: Avonex, Gilenya. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 11.58 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.43 sec. 9-hole peg non-dominant:27.85 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 7. DMT taken. Current DMT:mabthera- rituximab on February 01, 2019. Comments on DMT: Rebif, Tysabri, Gilenya. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 01, 2019. The 25-foot walk done. 25-foot walk test time was 7.7 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.89 sec. 9-hole peg non-dominant:23.47 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 25, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.7 sec. 9-hole peg non-dominant:22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation lhermitte . Number of attacks until the first visit:2. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Endocrine disorders. Name of co-morbidity:Depression. Visit diagnosis:nmo. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on February 01, 2010. Comments on DMT: Avonex - Rebif - Imuran. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.17 sec. 9-hole peg non-dominant:21.64 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on October 01, 2019. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:19.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Anemia. More information on co-morbidity:Anemia. Outcome:ongoing illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:rrms. Vit D at visit: 38.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 31, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.39 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.63 sec. 9-hole peg non-dominant:16.97 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.42. Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT: gilenya- fingolimod. Comments on DMT: Avonex. The 25-foot walk done. 25-foot walk test time was 2.98 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.05 sec. 9-hole peg non-dominant:18.38 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: non-smoker  EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:2. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mavenclad- cladribine on September 01, 2019. The 25-foot walk done. 25-foot walk test time was 3.26 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.12 sec. 9-hole peg non-dominant:20.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Mitoxantrone, rebif. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:75.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation gtc seizures. Has experienced progressive symptoms since onset. Name of co-morbidity:Surgeries. More information on co-morbidity:cholecystectomy. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:scoliosis. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:DM2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:seizures. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:tronchanteric bursitis. Outcome:completely recovered from illness. Visit diagnosis:ppms. DMT taken. Current DMT: methotrexate on December 01, 2014. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 6.07 sec. SDMT done. SDMT numerator: 31. SDMT denominator: 33. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.42 sec. 9-hole peg non-dominant:24.89 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.57. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:negative. IgG index in second:0.46. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:anterior uveitis. Outcome:completely recovered from illness. Name of co-morbidity:iridocorneal adhesions. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Name of co-morbidity:trigeminal neuralgia. Outcome:ongoing illness. Name of co-morbidity:prolactinemia 2ry to Tegretol. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Klebsiella pneumonia. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Visit diagnosis:vestibular migraine. Total relapses until visit: 3. There were new relapses since the previous visit. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The patient is in EDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Visit diagnosis:rrms. DMT taken. Current DMT: fumaderm on November 01, 2013. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 29, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 26 months?",
        "output":"After 26 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar, cognitive dysfunction. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2013. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 21. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24 sec. 9-hole peg non-dominant:27.3 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:71.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, optic neuritis, brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:spms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2011. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.9 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.4 sec. 9-hole peg non-dominant:29.2 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:change in diagnosis. New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2017. Comments on DMT: Betaferon, Gilenya. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 16, 2019. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 61 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:26.4 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 PPD. Vit D at visit: 70.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 62. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:16.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Coffee cups per week: 4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 20, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2020. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:19.4 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2012. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.79 sec. 9-hole peg non-dominant:20.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Rebif, Gilenya, Tecfidera. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:19.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2021. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.95 sec. 9-hole peg non-dominant:23 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 10. DMT taken. Current DMT:mabthera- rituximab on May 01, 2016. Comments on DMT: avonex, betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: March 16, 2020. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in second CSF:positive. IgG index in second:2.08. IgG index category in second CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Vit D at visit: 11.4. MRI of brain or spine done. Cervical spine MRI date: July 23, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 3.93 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.03 sec. 9-hole peg non-dominant:18.54 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Avonex or Cinnovex- IM Interferon. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.76. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Uveitis. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Behcet Disease. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. The 25-foot walk done. 25-foot walk test time was 6.12 sec. SDMT done. SDMT numerator: 38. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.84 sec. 9-hole peg non-dominant:23.39 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.91. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2021. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 34. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:23 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on November 01, 2020. Comments on DMT: Tecfidera. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 38.7. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 30, 2021. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 8.5 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:24.87 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:ACID REFLUX . Outcome:ongoing illness. Visit diagnosis:cis. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:16.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. OCBs in CSF:negative. OCBs in second CSF:positive. IgG index in second:0.71. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on May 01, 2017. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 25, 2022. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:7.97 sec. 9-hole peg non-dominant:32.7 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.629. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on July 01, 2019. Comments on DMT: Rebif. Vit D at visit: 66.4. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:19 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Name of co-morbidity:sinusitis. Name of co-morbidity:tinnitus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:16.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on July 01, 2020. Tobacco smoker: non-smoker  Vit D at visit: 62.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:21 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on April 08, 2013. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 01, 2017. The 25-foot walk done. 25-foot walk test time was 9.8 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:39.3 sec. 9-hole peg non-dominant:35.8 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2018. Comments on DMT: Aubagio; Betaferon. SDMT done. SDMT numerator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.1 sec. 9-hole peg non-dominant:23.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. OCBs in CSF:negative. Name of co-morbidity:Anemia. More information on co-morbidity:Normocytic anemia- Thallasemia ?. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2020. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: September 03, 2022. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:12.5 sec. 9-hole peg non-dominant:13.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2016. Vit D at visit: 54.29. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.6 sec. 9-hole peg non-dominant:18.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2015. Comments on DMT: Avonex - Betaseron. Vit D at visit: 27.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 29, 2017. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 71. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:14.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on March 01, 2018. Comments on DMT: Aubagio; Betaferon. Vit D at visit: 48.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: February 01, 2019. SDMT done. SDMT numerator: 24. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:33.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:myelitis. Total relapses until visit: 2. MRI of brain or spine done. Cervical spine MRI date: December 01, 2018. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.93 sec. 9-hole peg non-dominant:19.4 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2011. Comments on DMT: Avonex Betaferon. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 17.0. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: December 27, 2019. The 25-foot walk done. 25-foot walk test time was 4 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Comments on DMT: Rebif. Tobacco smoker: ex-smoker  Vit D at visit: 59.8. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 14, 2019. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.14 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.58 sec. 9-hole peg non-dominant:18.59 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2016. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: July 03, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.84 sec. 9-hole peg non-dominant:18.07 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:62.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.12. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2010. Tobacco smoker: non-smoker  Vit D at visit: 42.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 26, 2015. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.54 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.95 sec. 9-hole peg non-dominant:20.22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:1.5. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Imuran. MRI of brain or spine done. Cervical spine MRI date: April 28, 2015. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.82 sec. 9-hole peg non-dominant:19.09 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 18, 2013. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: May 09, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on March 01, 2019. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mavenclad- cladribine on August 01, 2021. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 6.2 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.6 sec. 9-hole peg non-dominant:36 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 27. SDMT denominator: 28. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.9 sec. 9-hole peg non-dominant:32 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, bowel\/bladder dysfunction. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:gilenya- fingolimod on December 09, 2013. Comments on DMT: Avonex - Rebif. Tobacco smoker: non-smoker  Vit D at visit: 87.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.85 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.62 sec. 9-hole peg non-dominant:17.86 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:23.46 sec. 9-hole peg non-dominant:74 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Fampyra. The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:seizures . Name of co-morbidity:learning disability . Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 24, 2019. Tobacco smoker: non-smoker  Vit D at visit: 31.0. The 25-foot walk done. 25-foot walk test time was 2.77 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.35 sec. 9-hole peg non-dominant:21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 02, 2002. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 103 months?",
        "output":"After 103 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Hyperthyroidism. Outcome:completely recovered from illness. Name of co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on January 01, 2015. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Vit D at visit: 27.2. MRI of brain or spine done. Cervical spine MRI date: June 01, 2019. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 16.9 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 42 months?",
        "output":"After 42 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: November 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.68. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Epilepsy. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on November 01, 2016. Comments on DMT: Avonex Rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 28. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.89 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:20.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.11. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: January 21, 2015. Received Gadolinium for Cervical spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.38 sec. SDMT done. SDMT numerator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:16.6 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar, bowel\/bladder dysfunction. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.79. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Bipolar disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tysabri- natalizumab on July 24, 2015. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:21.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:6. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on October 01, 2016. Tobacco smoker: non-smoker  Coffee cups per week: 21. Vit D at visit: 65.0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.13 sec. 9-hole peg non-dominant:20.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:25.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Seizures\/convulsions. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 0. DMT taken. Current DMT:avonex or cinnovex- im interferon on July 01, 2018. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:22.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:17.9 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:ACID REFLUX . Outcome:ongoing illness. Visit diagnosis:cis. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2011. Comments on DMT: Betaferon. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:18.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 06, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: Occasional. Alcohol drinsk per week: 1. Vit D at visit: 66.4. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 26, 2018. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.16 sec. 9-hole peg non-dominant:18.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:cis. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on May 01, 2019. SDMT done. SDMT numerator: 75. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:16.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Alcohol abuse disorder. Name of co-morbidity:Migraine. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mavenclad- cladribine on May 01, 2021. Comments on DMT: Tecfidera. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 05, 2022. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:21 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.8. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2011. The 25-foot walk done. 25-foot walk test time was 2.9 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.32 sec. 9-hole peg non-dominant:17.5 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:patient preference- convenience. New DMT:Plegridy (peginterferon beta 1-a). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 23, 2014. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.54. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 23, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18.9 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.55. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on October 27, 2016. Tobacco smoker: non-smoker  EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on December 01, 2015. Comments on DMT: Avonex 2010-Dec 2015. Tobacco smoker: non-smoker  Coffee cups per week: 1. Alcohol drinsk per week: 2. Vit D at visit: 45.2. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:21.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.3. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2014. Tobacco smoker: non-smoker  Vit D at visit: 38.3. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 01, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.55 sec. 9-hole peg non-dominant:20.84 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on June 24, 2022. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. Exercise hrs per week:4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 13, 2022. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2015. Comments on DMT: avonex, betaseron, tysabri, gilenya. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 20, 2018. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.3 sec. 9-hole peg non-dominant:16.7 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2018. Tobacco smoker: non-smoker  Vit D at visit: 59.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.76 sec. 9-hole peg non-dominant:18.4 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mavenclad- Cladribine. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:schizoaffective. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on November 30, 2012. Comments on DMT: Rebif, Betaferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). SDMT done. SDMT numerator: 25. SDMT denominator: 26. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:33 sec. 9-hole peg non-dominant:42.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.54. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14 sec. 9-hole peg non-dominant:16 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Visit diagnosis:rrms. MRI of brain or spine done. Cervical spine MRI date: January 05, 2012. The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.4 sec. 9-hole peg non-dominant:23 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 43 months?",
        "output":"After 43 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2020. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 7. Alcohol drinsk per week: 2. Exercise hrs per week:6. Vit D at visit: 44.3. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27 sec. 9-hole peg non-dominant:30 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on May 10, 2023. Tobacco smoker: non-smoker  Vit D at visit: 95.5. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 09, 2023. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.5 sec. 9-hole peg non-dominant:21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. OCBs in CSF:positive. IgG index in CSF:1.01. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2020. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:15 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Rheumatoid arhritis. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on January 01, 2019. Comments on DMT: gilenya, tysabri, cyclophosphamide. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 35.4. The 25-foot walk done. 25-foot walk test time was 6.2 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.75 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. Tobacco smoker: non-smoker  Alcohol drinsk per week: 2. SDMT done. SDMT numerator: 81. SDMT denominator: 81. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.51 sec. 9-hole peg non-dominant:17.09 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Breastfeeding . New DMT:Solumedrol- IV Methylprednisolone. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2017. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:24 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:2.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2014. Vit D at visit: 52.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 70. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:17.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2013. Comments on DMT: Betaferon, Gilenya. MRI of brain or spine done. No new lesions on Brain MRI. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. The patient is in EDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:gilenya- fingolimod on May 01, 2016. Comments on DMT: Avonex, Tysabri. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.2 sec. 9-hole peg non-dominant:20 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:53.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.51. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2018. Tobacco smoker: non-smoker  Coffee cups per week: 21. Alcohol drinsk per week: 1. Exercise hrs per week:6. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.4 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:nmo. DMT taken. Current DMT:mabthera- rituximab on October 01, 2012. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: February 16, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:19.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on July 01, 2021. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 01, 2022. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.6 sec. 9-hole peg non-dominant:16.4 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.86. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. Visit diagnosis:rrms. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 27, 2012. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The patient is in EDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tysabri- natalizumab on June 01, 2013. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 04, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on August 01, 2016. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.39 sec. 9-hole peg non-dominant:28.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. Total relapses until visit: 2. Comments on DMT: Cyclophosphamide - Syncathen. The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. SDMT done. SDMT numerator: 8. SDMT denominator: 10. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:154.31 sec. EDSS:9- helpless bed patient; can communicate and eat. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Rash. Outcome:completely recovered from illness. Total relapses until visit: 2. Vit D at visit: 22.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25.19 sec. 9-hole peg non-dominant:22.86 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on July 01, 2017. Comments on DMT: Avonex - Rebif. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. OCBs in CSF:positive. IgG index in CSF:0.81. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. DMT taken. Current DMT:mabthera- rituximab on March 01, 2021. Tobacco smoker: ex-smoker  The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 01, 2011. Comments on DMT: Betaferon - Mabthera - Monthly steroids. The 25-foot walk done. 25-foot walk test time was 12.2 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 23 months?",
        "output":"After 23 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Initial presentation incidental mri findings. OCBs in CSF:positive. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:ris. Total relapses until visit: 0. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: December 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.18 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.13 sec. 9-hole peg non-dominant:18.12 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.48. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on December 28, 2017. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 07, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 2.82 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.52 sec. 9-hole peg non-dominant:20.28 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Has experienced progressive symptoms since onset. Name of co-morbidity:Spinal cord compression. Outcome:ongoing illness. Visit diagnosis:ppms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on June 01, 2022. Tobacco smoker: current  Tobacco type: cigarette or cigar. The 25-foot walk done. 25-foot walk test time was 5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:38 sec. 9-hole peg non-dominant:42 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2018. Comments on DMT: Rebif (Sep 2009-Dec 2016). MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.9 sec. 9-hole peg non-dominant:16 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation expressive aphasia. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2020. Tobacco smoker: ex-smoker  Vit D at visit: 92.0. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 40. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:21 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.629. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:24.4 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. Comments on DMT: Rebif . Tobacco smoker: non-smoker  SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:163 sec. 9-hole peg non-dominant:31 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Endoxan- Cyclophosphamide. The patient is in NEDA. Will the patient be in NEDA or EDA after 25 months?",
        "output":"After 25 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 01, 2015. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.32 sec. SDMT done. SDMT numerator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.1 sec. 9-hole peg non-dominant:19.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 1998. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 68 months?",
        "output":"After 68 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. DMT taken. Current DMT:tysabri- natalizumab on December 01, 2015. Comments on DMT: Rebif. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.74 sec. 9-hole peg non-dominant:18 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:8. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:47.7 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.88. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: October 16, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.7 sec. 9-hole peg non-dominant:22.4 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.29. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:abortion. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on June 18, 2015. Comments on DMT: Rebif. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:2.43. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2011. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1 cigarette daily. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 6.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 48 months?",
        "output":"After 48 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on June 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. Exercise hrs per week:5. Vit D at visit: 37.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: February 12, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 91. SDMT denominator: 91. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:18 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Sclemod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2021. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.16 sec. 9-hole peg non-dominant:24.9 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:72.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on September 01, 2017. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: May 21, 2018. The 25-foot walk done. 25-foot walk test time was 100 sec. SDMT done. SDMT numerator: 16. SDMT denominator: 17. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:125 sec. 9-hole peg non-dominant:99 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:appendectomy . Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. Comments on DMT: Mabthera, Aubagio, Rebif. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:18.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. OCBs in CSF:positive. IgG index in CSF:0.87. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:aubagio- teriflunomide on September 01, 2019. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 3.25 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.62 sec. 9-hole peg non-dominant:24.06 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 1999. Vit D at visit: 58.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 5.42 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.61 sec. 9-hole peg non-dominant:20.45 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:75.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2008. The 25-foot walk done. 25-foot walk test time was 8.4 sec. SDMT done. SDMT numerator: 24. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:46 sec. 9-hole peg non-dominant:30 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:3. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on June 01, 2013. Comments on DMT: Avonex - Cyclophosphamide. The 25-foot walk done. 25-foot walk test time was 6.75 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.07 sec. 9-hole peg non-dominant:47.36 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on July 24, 2019. Comments on DMT: tecfidera. Tobacco smoker: non-smoker  Vit D at visit: 61.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.8 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:22.92 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2012. Comments on DMT: Betaferon. Tobacco smoker: non-smoker  Vit D at visit: 9.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: February 08, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 2. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 7 sec. SDMT done. SDMT numerator: 30. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.3 sec. 9-hole peg non-dominant:28.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:1.46. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Mild mental retardation. Outcome:ongoing illness. Name of co-morbidity:Chronic Hepatitis B. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on September 24, 2020. Comments on DMT: tecfidera. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 5.5 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22 sec. 9-hole peg non-dominant:23.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:21.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.72. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. The 25-foot walk done. 25-foot walk test time was 3.8 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:2. OCBs in second CSF:positive. OCBs in third CSF:positive. IgG index in third CSF:0.52. IgG index category in third CSF:Normal (< 0.77). Name of co-morbidity:schizoaffective. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: gilenya- fingolimod. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 4.78 sec. SDMT done. SDMT numerator: 27. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:28.5 sec. 9-hole peg non-dominant:31.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, incidental mri findings. OCBs in CSF:negative. IgG index in CSF:999. Visit diagnosis:rrms. Total relapses until visit: 3. There were new relapses since the previous visit. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Vit D at visit: 24.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 06, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.85 sec. 9-hole peg non-dominant:22.5 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension. Visit diagnosis:spms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on September 01, 2021. Comments on DMT: Avonex, Rebif, Gilenya, Siponimod. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: September 01, 2021. The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 34. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:32 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2018. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 26, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:15.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 12, 2019. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.1 sec. 9-hole peg non-dominant:20.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.38. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on June 23, 2017. Comments on DMT: Rebif. Vit D at visit: 55.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 26, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.2 sec. 9-hole peg non-dominant:18.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: Hb weekly. Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 05, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.37 sec. 9-hole peg non-dominant:20.24 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2016. Vit D at visit: 69.1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: January 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 67. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:18.9 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation brainstem, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.43. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 2. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: May 01, 2023. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:22 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Rheumatoid arhritis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. MRI of brain or spine done. No new lesions on Brain MRI. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:2.08. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on April 01, 2015. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory, motor weakness. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:autoimmune alopecia universalis. Outcome:ongoing illness. Name of co-morbidity:congenital vision loss in right eye. Outcome:ongoing illness. Name of co-morbidity:nail dystrophy. Outcome:ongoing illness. Name of co-morbidity:hereditary senosry motor demyelinating neuropathy. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on May 01, 2017. Comments on DMT: imuran. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.6 sec. 9-hole peg non-dominant:25.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2018. Vit D at visit: 57.7. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 01, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 50. 9-HPT done. Dominant hand:Right.  9-hole peg dominant:16.1 sec. 9-hole peg non-dominant:16.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.85. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Rheumatoid arhritis. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. Assistance required for 25-foot walk test: Bilateral assistance by a person. 25-foot walk test time was 23 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31.9 sec. 9-hole peg non-dominant:30.9 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on March 01, 2015. Comments on DMT: Betaferon- Tysabri. Tobacco smoker: non-smoker  Vit D at visit: 29.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: November 03, 2015. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 6.3 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.33 sec. 9-hole peg non-dominant:26.56 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on July 01, 2017. Comments on DMT: Failed Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 40. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:18 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. Vit D at visit: 91.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 14, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.26 sec. SDMT done. SDMT numerator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:21.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:67.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis, sarcoidosis. OCBs in CSF:negative. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Diabetes mellitus type 3. Outcome:ongoing illness. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:nmo. Several relapses until this visit. DMT taken. Current DMT: cellcept and monthly ivig on May 01, 2011. Comments on DMT: Mabthera, monthly IVMP. MRI of brain or spine done. No new lesions on Brain MRI. The patient is in EDA. Will the patient be in NEDA or EDA after 48 months?",
        "output":"After 48 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on July 10, 2020. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 48.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: January 22, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:19 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 33 months?",
        "output":"After 33 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar, incidental mri findings. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on January 18, 2016. Comments on DMT: gilenya. Tobacco smoker: non-smoker  Coffee cups per week: 7. The 25-foot walk done. 25-foot walk test time was 6 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.8 sec. 9-hole peg non-dominant:32.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Endometriosis. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on August 25, 2014. Comments on DMT: Betaferon. Tobacco smoker: non-smoker  Coffee cups per week: 14. Alcohol drinsk per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:19.77 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2011. MRI of brain or spine done. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Endoxan- Cyclophosphamide. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. IgG index in CSF:0.98. IgG index category in CSF:High IgG index (> or = 0.77). OCBs in second CSF:positive. IgG index in second:0.8. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 4. The 25-foot walk done. 25-foot walk test time was 4.32 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:7.8 sec. 9-hole peg non-dominant:20.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 01, 2013. Vit D at visit: 43.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 30, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.75 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.11 sec. 9-hole peg non-dominant:17.39 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:29.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 01, 2015. Comments on DMT: REBIF. Vit D at visit: 110.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:18.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on March 01, 2013. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 12, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.91 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.57 sec. 9-hole peg non-dominant:18.5 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT: tecfidera-dimethylfumarate. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.94 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.93 sec. 9-hole peg non-dominant:23.45 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.82. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:hearing problem. Name of co-morbidity:thrombocytopenia medication induced. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on October 01, 2011. Comments on DMT: beatferon, rituximab. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 92.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 01, 2019. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 7.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.6 sec. 9-hole peg non-dominant:20.8 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.19. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2014. Comments on DMT: Betaferon (Oct 2007-Jan 2012); Gilenya (Mar 2012-Nov 2013). Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 2.9 sec. SDMT done. SDMT numerator: 63. SDMT denominator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.4 sec. 9-hole peg non-dominant:21.9 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on January 01, 2016. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:cis. Total relapses until visit: 1. The 25-foot walk done. 25-foot walk test time was 4.7 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.8 sec. 9-hole peg non-dominant:23.12 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on March 01, 2020. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 6.3 sec. SDMT done. SDMT numerator: 39. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.2 sec. 9-hole peg non-dominant:20 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. Tobacco smoker: non-smoker  Coffee cups per week: 15. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 3. Cervical spine MRI date: November 01, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.8 sec. 9-hole peg non-dominant:19.2 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in NEDA. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.607. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. SDMT done. SDMT numerator: 42. SDMT denominator: 42. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:16.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:3. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Betaferon. The 25-foot walk done. 25-foot walk test time was 7 sec. SDMT done. SDMT numerator: 30. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.3 sec. 9-hole peg non-dominant:28.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Remarks about CSF: but the results of the LP were not known. Name of co-morbidity:Epilepsy . Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.18 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.39 sec. 9-hole peg non-dominant:27.13 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.864. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Essential tremor. Outcome:ongoing illness. Visit diagnosis:rrms. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 1 HB\/week. Vit D at visit: 30.1. MRI of brain or spine done. Cervical spine MRI date: February 22, 2014. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 4.05 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2013. Comments on DMT: Avonex March 2013 until Oct 2013. The 25-foot walk done. 25-foot walk test time was 3.68 sec. SDMT done. SDMT numerator: 74. SDMT denominator: 74. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.59 sec. 9-hole peg non-dominant:20.28 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.64. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on January 01, 2015. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 01, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 70. SDMT denominator: 71. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:22.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on June 15, 2015. Comments on DMT: Cinnovex Rebif Mycophenolate. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 26, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:18.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 8. DMT taken. Current DMT:mabthera- rituximab on June 01, 2009. Comments on DMT: Avonex. Vit D at visit: 46.2. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.9 sec. 9-hole peg non-dominant:18.06 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. There were new relapses since the previous visit. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2015. Comments on DMT: Avonex, Gilenya. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 10. Total T1 Gad-enhancing lesions in Brain: 5. Cervical spine MRI date: May 16, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.38 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.09 sec. 9-hole peg non-dominant:22.41 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to relapses AND new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:gastric sleeve. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2012. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.8 sec. 9-hole peg non-dominant:21 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on August 27, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.5 PPD. The 25-foot walk done. 25-foot walk test time was 6.9 sec. SDMT done. SDMT numerator: 23. SDMT denominator: 24. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:29.2 sec. 9-hole peg non-dominant:33.11 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2018. Tobacco smoker: non-smoker  Alcohol drinsk per week: 2. Exercise hrs per week:6. The 25-foot walk done. 25-foot walk test time was 3 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.79 sec. 9-hole peg non-dominant:17.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on February 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.16 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.91 sec. 9-hole peg non-dominant:26.77 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 20, 2019. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:17 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). More information on co-morbidity:Schizoaffective disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2017. Comments on DMT: tecfidera. MRI of brain or spine done. The patient is in EDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:prolactinoma. Outcome:ongoing illness. Name of co-morbidity:degenrative disk disease. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:chronic constipation. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2020. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: May 20, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.9 sec. 9-hole peg non-dominant:15.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation incidental mri findings. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Vit D at visit: 63.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: December 28, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 53. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:19.3 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. OCBs in CSF:positive. IgG index in CSF:1.01. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on March 06, 2020. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.6 sec. 9-hole peg non-dominant:17 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). OCBs in second CSF:positive. IgG index in second:0.83. IgG index category in second CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2021. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 33. SDMT denominator: 35. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:17.5 sec. 9-hole peg non-dominant:21.5 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:20.  Gender:female.  Diagnosis:mog disease. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:congenital aortic stenosis and regurge. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on July 01, 2020. Comments on DMT: Rituximab. Tobacco smoker: non-smoker  Anti-MOG Abs seropositivity: Negative. Anti-MOG Abs denominator titer: 1:10. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:change in diagnosis. New DMT:Tysabri- Natalizumab. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:32.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:1.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on October 01, 2013. Comments on DMT: Avonex 2012-2013. Tobacco smoker: current  Tobacco type: water-pipe. Vit D at visit: 45.4. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 76. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:22.1 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:ACID REFLUX . Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 3. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. Comments on DMT: Betaferon - Rebif. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:0.61. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:spms. Total relapses until visit: 5. DMT taken. Current DMT:mabthera- rituximab on September 18, 2017. Comments on DMT: Rebif, Avonex. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 7.4 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 39. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.9 sec. 9-hole peg non-dominant:23 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:46.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:Urinary tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Renal disorders. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on January 01, 2017. Comments on DMT: Avonex and Gilenya. Vit D at visit: 61.0. MRI of brain or spine done. Cervical spine MRI date: July 02, 2018. The 25-foot walk done. 25-foot walk test time was 5.2 sec. SDMT done. SDMT numerator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.9 sec. 9-hole peg non-dominant:19.6 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2020. Tobacco smoker: ex-smoker  Exercise hrs per week:4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: February 19, 2021. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:20 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:2.43. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: February 01, 2022. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:21.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:79.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation brainstem. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.71. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Name of co-morbidity:Alzheimer's. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. Outcome:ongoing illness. Name of co-morbidity:Urinary tract infection. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Skin disorder. More information on co-morbidity:Pityriasis versicolor. Outcome:completely recovered from illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:delayed gastric emptying. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 21, 2007. Comments on DMT:  + Imuran. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:46.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.682. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:rosacea . Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on April 11, 2019. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:asthma. Outcome:completely recovered from illness. Name of co-morbidity:Keratoconus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2014. Vit D at visit: 37.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: May 19, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.82 sec. SDMT done. SDMT numerator: 85. SDMT denominator: 86. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.81 sec. 9-hole peg non-dominant:17.31 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.44 sec. 9-hole peg non-dominant:18.91 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Plegridy (peginterferon beta 1-a). The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:53.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2006. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: May 01, 2018. Cervical spine MRI: T2 lesions, not gad-enhancing. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tysabri- Natalizumab. The patient is in EDA due to new MRI lesions AND EDSS changes. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:20.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. Visit diagnosis:rrms. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:19.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:24.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.81. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Eczema. Outcome:ongoing illness. Name of co-morbidity:Asthma. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on July 04, 2018. Comments on DMT: Aubagio. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: June 10, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.35 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:25 sec. 9-hole peg non-dominant:26.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.58. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2016. Vit D at visit: 20.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 14, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4.08 sec. SDMT done. SDMT numerator: 65. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.6 sec. 9-hole peg non-dominant:18.05 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:27.  Gender:male.  Diagnosis:mog disease. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. Visit diagnosis:mog. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.3 sec. 9-hole peg non-dominant:24.3 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:57.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Visit diagnosis:ris. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.94 sec. SDMT done. SDMT numerator: 63. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.41 sec. 9-hole peg non-dominant:20.69 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on November 11, 2011. Comments on DMT: Avone 2009 Rebif(2009) Betaferon(2009-2010) Methotrexate(2009-2010) Tysabri(2010-2011). MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: September 17, 2012. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, brainstem. OCBs in CSF:positive. IgG index in CSF:0.55. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:HTN. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Coffee cups per week: 35. Vit D at visit: 18.0. Anti-MOG Abs seropositivity: Negative. MRI of brain or spine done. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on November 07, 2014. Comments on DMT: Rebif sept 12 - oct 14. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Tobacco type: 1 PPD +1hb. Coffee cups per week: 21. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.4 sec. 9-hole peg non-dominant:22.8 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:ris. Has not converted to SPMS. Visit diagnosis:ris. Total relapses until visit: 0. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 58. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:13.48 sec. 9-hole peg non-dominant:17.38 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 19, 2016. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 5.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23 sec. 9-hole peg non-dominant:20 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:38.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:3. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on October 01, 2014. Comments on DMT: Avonex, Rebif. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.33 sec. SDMT done. SDMT numerator: 82. SDMT denominator: 82. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.36 sec. 9-hole peg non-dominant:14.59 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. Outcome:completely recovered from illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Vitamin B 12 deficiency. Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on February 01, 2018. The 25-foot walk done. 25-foot walk test time was 11.83 sec. SDMT done. SDMT numerator: 17. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.9 sec. 9-hole peg non-dominant:31.2 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:mabthera- rituximab on December 01, 2018. Comments on DMT: Rebif, Aubagio, Gilenya. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 11, 2021. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.3 sec. SDMT done. SDMT numerator: 43. SDMT denominator: 43. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:17.8 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:1.29. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on December 01, 2017. Comments on DMT: mabthera, rebif. Tobacco smoker: current  Tobacco type: cigarette or cigar. Vit D at visit: 47.8. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: February 24, 2020. Received Gadolinium for Thoracic (dorsal) spine MRI. The 25-foot walk done. Assistance required for 25-foot walk test: AFO. 25-foot walk test time was 9 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.9 sec. 9-hole peg non-dominant:22.6 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:65.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2015. Tobacco smoker: non-smoker  Exercise hrs per week:2. Vit D at visit: 43.6. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: August 29, 2016. The 25-foot walk done. 25-foot walk test time was 4.9 sec. SDMT done. SDMT numerator: 37. SDMT denominator: 37. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.59 sec. 9-hole peg non-dominant:31.03 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.47. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2016. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. Exercise hrs per week:5. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 04, 2021. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:23.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 29 months?",
        "output":"After 29 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:68.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 1.5ppd. Coffee cups per week: 35. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.8 sec. 9-hole peg non-dominant:19.2 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:5. OCBs in CSF:positive. IgG index in CSF:2.12. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on May 11, 2016. Comments on DMT: Avonex, Betaferon. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.38 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.13 sec. 9-hole peg non-dominant:28.83 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar, cognitive dysfunction. Has experienced progressive symptoms since onset. Visit diagnosis:ppms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on May 01, 2012. MRI of brain or spine done. Cervical spine MRI date: November 18, 2013. The 25-foot walk done. Assistance required for 25-foot walk test: Unilateral assistance by a person. 25-foot walk test time was 26 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA. Will the patient be in NEDA or EDA after 20 months?",
        "output":"After 20 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:4. Name of co-morbidity:Asthma. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on June 08, 2020. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 88. SDMT denominator: 88. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:18.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Diabetes mellitus type 2. More information on co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on August 01, 2016. MRI of brain or spine done. Cervical spine MRI date: April 10, 2017. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Visit diagnosis:spms. DMT taken. Current DMT:mabthera- rituximab on March 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. Assistance required for 25-foot walk test: Walker. 25-foot walk test time was 52 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:35.3 sec. 9-hole peg non-dominant:26 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2017. Vit D at visit: 45.4. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Cervical spine MRI date: January 01, 2018. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.4 sec. 9-hole peg non-dominant:18.1 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 41 months?",
        "output":"After 41 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Has experienced progressive symptoms since onset. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:ppms. Total relapses until visit: 0. Comments on DMT: Rebif. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 14, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 18.75 sec. SDMT done. SDMT numerator: 19. SDMT denominator: 23. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.83 sec. 9-hole peg non-dominant:67.61 sec. EDSS:6.5- constant bilateral assistance (canes or crutches) required to walk at least 20 meters without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. MRI of brain or spine done. Cervical spine MRI date: April 26, 2018. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Ocrevus - Ocrelizumab. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, cerebellar. Number of attacks until the first visit:1. Name of co-morbidity:Absence Seizures. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.96 sec. 9-hole peg non-dominant:16.53 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Avonex, Mitoxantrone. The 25-foot walk done. 25-foot walk test time was 6.09 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.19 sec. 9-hole peg non-dominant:23.59 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:asthma. Outcome:completely recovered from illness. Name of co-morbidity:Keratoconus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on June 01, 2017. The 25-foot walk done. 25-foot walk test time was 3.51 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.1 sec. 9-hole peg non-dominant:17.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.65. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on March 01, 2019. Comments on DMT: rebif. Tobacco smoker: ex-smoker  Vit D at visit: 44.5. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 01, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.6 sec. 9-hole peg non-dominant:17.3 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 19 months?",
        "output":"After 19 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2012. MRI of brain or spine done. Cervical spine MRI date: September 08, 2015. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.75 sec. 9-hole peg non-dominant:17.97 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: Occasional. Alcohol drinsk per week: 1. MRI of brain or spine done. Cervical spine MRI date: October 21, 2015. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 53. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:18.67 sec. 9-hole peg non-dominant:16.82 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 2 months?",
        "output":"After 2 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.99. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Visit diagnosis:nmo. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on April 01, 2018. Comments on DMT: Rebif. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.5 sec. 9-hole peg non-dominant:18.5 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.36. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Vit D at visit: 18.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: August 29, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 62. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.49 sec. 9-hole peg non-dominant:18.65 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation brainstem. Number of attacks until the first visit:1. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on August 12, 2020. Comments on DMT: Rebif, Gilenya. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. Exercise hrs per week:2. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 35. SDMT denominator: 38. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.36 sec. 9-hole peg non-dominant:23.3 sec. EDSS:4.5- ambulatory without aid or rest for less than 300 meters; up and about much of the day, characterized by relatively severe disability usually consisting of one FS grade 4 and combination of lesser grades exceeding limits of previous steps. The patient is in EDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. Comments on DMT: Gilenya. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 63 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:31 sec. 9-hole peg non-dominant:28 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:45.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:1.45. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on June 01, 2017. Comments on DMT: Aubagio, Rebif. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: October 09, 2018. The 25-foot walk done. 25-foot walk test time was 3.36 sec. SDMT done. SDMT numerator: 66. SDMT denominator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:19.7 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. Visit diagnosis:rrms. DMT taken. Current DMT:mabthera- rituximab on September 01, 2021. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 67. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16 sec. 9-hole peg non-dominant:16.5 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:male.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:cis. DMT taken. Current DMT:avonex or cinnovex- im interferon on July 01, 2013. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 2 hubble bubble per week. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: June 23, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.51 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.09 sec. 9-hole peg non-dominant:21.97 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.74. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Upper respiratory tract infection. More information on co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT: tysabri- natalizumab. Comments on DMT: Avonex. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.8 sec. 9-hole peg non-dominant:24.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.56. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on October 01, 2019. Tobacco smoker: current  Tobacco type: cigarette or cigar. Alcohol drinsk per week: 1. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.77 sec. 9-hole peg non-dominant:15.92 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on October 11, 2011. Comments on DMT: Avonex Sep 2010-Mar 2011, Betaferon May 2011-Sep 2011. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: occasionally. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 28, 2017. The 25-foot walk done. 25-foot walk test time was 4.4 sec. SDMT done. SDMT numerator: 40. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.9 sec. 9-hole peg non-dominant:20.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 18 months?",
        "output":"After 18 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:negative. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Tobacco smoker: non-smoker  MRI of brain or spine done. Cervical spine MRI date: January 02, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.8 sec. SDMT done. SDMT numerator: 55. SDMT denominator: 55. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26 sec. 9-hole peg non-dominant:26.7 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:3.04. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:vascular malformation in right forearm. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2013. Tobacco smoker: non-smoker  Coffee cups per week: 14. Vit D at visit: 77.8. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 5. Total T1 Gad-enhancing lesions in Brain: 2. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.01 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:19.7 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.63. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Oral Candidiasis. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on May 01, 2017. Vit D at visit: 44.0. The 25-foot walk done. 25-foot walk test time was 3.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:18.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:76.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.52. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS. Outcome:ongoing illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Disk surgery. Outcome:completely recovered from illness. Name of co-morbidity:Dyslipidemia. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Right ear congenital hearing loss. Outcome:ongoing illness. Name of co-morbidity:Tooth abscess + extraction. Outcome:completely recovered from illness. Name of co-morbidity:Herpse Zoster. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Total Left hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 5. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 01, 2009. Comments on DMT: atoricept trial. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:54.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:nmo. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 29, 2019. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 15, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.52 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: unable with the right hand. Dominant hand:Right. 9-hole peg non-dominant:18.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:56.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on October 11, 2011. Comments on DMT: Avonex Sep 2010-Mar 2011, Betaferon May 2011-Sep 2011. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: occassionally. Coffee cups per week: 14. The 25-foot walk done. 25-foot walk test time was 4.47 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:21.52 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Name of co-morbidity:Anxiety. More information on co-morbidity:Anxiety. Outcome:ongoing illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:Musculoskeletal. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:mabthera- rituximab on July 01, 2013. Comments on DMT: Avonex (2005-2007), Rebif (2007-2008), Betaferon (Sep 2009-July 2010), Tysabri (Aug 2010-Aug 2011), Gilenya (Nov 2012-June 2013). Tobacco smoker: non-smoker  Vit D at visit: 60.8. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 73. SDMT denominator: 73. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.59 sec. 9-hole peg non-dominant:20.72 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:tecfidera-dimethylfumarate on July 01, 2017. Tobacco smoker: ex-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 84. SDMT denominator: 84. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:17.83 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:1.15. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 29, 2019. Tobacco smoker: ex-smoker  Exercise hrs per week:5. Vit D at visit: 45.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: July 01, 2019. Received Gadolinium for Cervical spine MRI. Received Gadolinium for Thoracic (dorsal) spine MRI. The 25-foot walk done. 25-foot walk test time was 3.86 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:24.33 sec. 9-hole peg non-dominant:28.71 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA. Will the patient be in NEDA or EDA after 39 months?",
        "output":"After 39 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:asthma. Outcome:completely recovered from illness. Name of co-morbidity:Keratoconus. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:avonex or cinnovex- im interferon on January 01, 2014. Tobacco smoker: non-smoker  Coffee cups per week: 21. Alcohol drinsk per week: 1. Vit D at visit: 51.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: August 01, 2014. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.18 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 80. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.68 sec. 9-hole peg non-dominant:16.86 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:55.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:BPH. Outcome:ongoing illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:papillary urothelial cancer . Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on January 01, 2019. Comments on DMT: avonex, rebif. Tobacco smoker: ex-smoker  The 25-foot walk done. 25-foot walk test time was 5 sec. SDMT done. SDMT numerator: 20. SDMT denominator: 21. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:26.4 sec. 9-hole peg non-dominant:25 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:52.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:0.93. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:aubagio- teriflunomide on January 01, 2017. The patient is in NEDA. Will the patient be in NEDA or EDA after 37 months?",
        "output":"After 37 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.48. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. Vit D at visit: 25.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: March 11, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.2 sec. SDMT done. SDMT numerator: 58. SDMT denominator: 59. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:21.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 43 months?",
        "output":"After 43 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.864. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Hypothyroidism. More information on co-morbidity:Hypothyroidism. Outcome:ongoing illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Essential tremor. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2015. Comments on DMT: Avonex. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.11 sec. 9-hole peg non-dominant:20.7 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:35.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.88. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on April 01, 2014. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: March 16, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.1 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.49 sec. 9-hole peg non-dominant:20.36 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:58.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on March 01, 2020. The 25-foot walk done. 25-foot walk test time was 8.5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:60 sec. 9-hole peg non-dominant:38 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. Visit diagnosis:rrms. Total relapses until visit: 5. Comments on DMT: Rebif  (May 2016 until June 2017)- Gilenya  (June 2017 - October 2017) Tecfidera (December 202. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 59. SDMT denominator: 60. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:18 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in NEDA. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:45.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.53. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on November 01, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: January 23, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 3.4 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17 sec. 9-hole peg non-dominant:21 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:31.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:6. OCBs in CSF:negative. IgG index in CSF:0.45. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on June 30, 2022. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 2. Alcohol drinsk per week: 1. The patient is in NEDA. Will the patient be in NEDA or EDA after 15 months?",
        "output":"After 15 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2016. Comments on DMT: Avonex. Vit D at visit: 56.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 04, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Evidence of LETM. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 77. SDMT denominator: 77. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.1 sec. 9-hole peg non-dominant:18.5 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:49.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Migraine. More information on co-morbidity:Migraine. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Genito-urinary. More information on co-morbidity:Genitourinary. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2013. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: May 21, 2018. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 14. SDMT denominator: 20. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20 sec. 9-hole peg non-dominant:23.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.78. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Blood and lymphatic disorders. Outcome:completely recovered from illness. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on September 01, 2020. The 25-foot walk done. 25-foot walk test time was 3.1 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.7 sec. 9-hole peg non-dominant:16 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.83. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Skin disorder. More information on co-morbidity:Skin disorder. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on April 01, 2013. Comments on DMT: Rebif. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: March 29, 2016. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.13 sec. SDMT done. SDMT numerator: 87. SDMT denominator: 87. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.64 sec. 9-hole peg non-dominant:17.89 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:51.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:completely recovered from illness. Name of co-morbidity:VZV Trigeminal neuritis. Outcome:completely recovered from illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on December 14, 2015. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: July 01, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:32.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on October 01, 2020. Tobacco smoker: ex-smoker  Coffee cups per week: 7. Exercise hrs per week:2. MRI of brain or spine done. No new lesions on Brain MRI. Cervical spine MRI date: September 26, 2022. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 60. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18 sec. 9-hole peg non-dominant:19 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on October 01, 2009. Tobacco smoker: non-smoker  Coffee cups per week: 7. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: October 14, 2013. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 47. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:30.2 sec. 9-hole peg non-dominant:30.6 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:34.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on November 04, 2011. The patient is in EDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:20.  Gender:female.  Diagnosis:mog disease. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:congenital aortic stenosis and regurge. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:gilenya- fingolimod on January 01, 2021. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 68. SDMT denominator: 68. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.2 sec. 9-hole peg non-dominant:19.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:1. OCBs in CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hepatic disorders. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 0.15 PPD. Coffee cups per week: 7. Alcohol drinsk per week: 1. Vit D at visit: 51.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.78 sec. SDMT done. SDMT numerator: 75. SDMT denominator: 75. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.8 sec. 9-hole peg non-dominant:20.91 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.94. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on January 01, 2018. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 31 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:32.5 sec. 9-hole peg non-dominant:29.72 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:4. OCBs in CSF:positive. IgG index in CSF:0.98. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 5. There were new relapses since the previous visit. Tobacco smoker: non-smoker  Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Rebif or Betaferon or Recigen- SQ Interferon. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:1.26. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:ppms. DMT taken. Current DMT:ocrevus - ocrelizumab on August 01, 2018. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 1 months?",
        "output":"After 1 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:58.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:10. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 6. DMT taken. Current DMT:mabthera- rituximab on June 01, 2017. Comments on DMT: Betaferon, Arava. Tobacco smoker: current  Tobacco type: water-pipe. Coffee cups per week: 14. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 10, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 5.8 sec. SDMT done. SDMT numerator: 32. SDMT denominator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.9 sec. 9-hole peg non-dominant:25.7 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:70.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:aubagio- teriflunomide on September 01, 2018. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 5.6 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.3 sec. 9-hole peg non-dominant:20.7 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on June 23, 2015. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Cervical spine MRI date: August 25, 2016. The 25-foot walk done. 25-foot walk test time was 3.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19 sec. 9-hole peg non-dominant:19.2 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:27.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.9. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on September 01, 2013. Comments on DMT: Avonex. Tobacco smoker: non-smoker  Coffee cups per week: 7. Vit D at visit: 58.7. MRI of brain or spine done. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 2. Cervical spine MRI date: January 27, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.35 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.11 sec. 9-hole peg non-dominant:23.82 sec. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Gilenya- Fingolimod. The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 17 months?",
        "output":"After 17 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. IgG index in CSF:1.63. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2016. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.7 sec. 9-hole peg non-dominant:17.8 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:44.  Gender:male.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Has experienced progressive symptoms since onset. OCBs in CSF:positive. Visit diagnosis:ppms. Total relapses until visit: 0. Comments on DMT: Interferon - Imuran - Mitoxantrone. Vit D at visit: 39.9. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). The 25-foot walk done. Assistance required for 25-foot walk test: Unable to walk. 25-foot walk test time was 29.4 sec. SDMT done. SDMT numerator: 22. SDMT denominator: 22. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:99 sec. EDSS:7- unable to walk 5 meters even with aid, essentially restricted to wheelchair; wheels self and transfers alone; up and about in wheelchair some 12 hours a day. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA. Will the patient be in NEDA or EDA after 22 months?",
        "output":"After 22 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:27.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. IgG index in CSF:0.7. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on July 14, 2021. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. Coffee cups per week: 1. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: June 01, 2022. Cervical spine MRI: T2 lesion, unknown enhancement (MRI without gad). Number of new T2 lesions in Cervical spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 46. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.4 sec. 9-hole peg non-dominant:19.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:GERD. Name of co-morbidity:Anemia. More information on co-morbidity:Thalassemia minor. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:avonex or cinnovex- im interferon on September 01, 2009. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 13, 2013. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 85. SDMT denominator: 85. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21 sec. 9-hole peg non-dominant:21 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. DMT taken. Current DMT:ocrevus - ocrelizumab on June 01, 2018. Vit D at visit: 28.4. The 25-foot walk done. 25-foot walk test time was 7.5 sec. SDMT done. SDMT numerator: 29. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:27023 sec. 9-hole peg non-dominant:21.34 sec. EDSS:4- ambulatory without aid or rest for \u00e2\u2030\u00a5500 meters; up and about some 12 hours a day despite relatively severe disability consisting of one FS grade 4 (others 0 or 1) or combinations of lesser grades exceeding limits of previous steps. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Bipolar disorder. Visit diagnosis:rrms. DMT taken. Current DMT:gilenya- fingolimod on December 01, 2017. MRI of brain or spine done. Cervical spine MRI date: July 03, 2018. The 25-foot walk done. 25-foot walk test time was 5.4 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:24.2 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:39.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:4. OCBs in CSF:positive. Name of co-morbidity:Hypothyroidism. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Tysabri; Avonex; Rebif. MRI of brain or spine done. Cervical spine MRI date: June 11, 2019. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:14.8 sec. 9-hole peg non-dominant:17.25 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:33.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory, cerebellar. Number of attacks until the first visit:7. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on January 01, 2015. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.2 sec. SDMT done. SDMT numerator: 28. SDMT denominator: 29. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.34 sec. 9-hole peg non-dominant:21.26 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:change in diagnosis. New DMT:Mabthera- Rituximab. The patient is in EDA due to relapses. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:ppms. The patient is in NEDA. Will the patient be in NEDA or EDA after 14 months?",
        "output":"After 14 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 2. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 1. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 69. SDMT denominator: 69. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.77 sec. 9-hole peg non-dominant:18.74 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. The patient is in EDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.17. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:gilenya- fingolimod on March 01, 2014. Comments on DMT: Rebif. Tobacco smoker: current  The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.8 sec. 9-hole peg non-dominant:19 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on March 01, 2014. Tobacco smoker: current  Tobacco type: water-pipe. Tobacco type: 1 HB\/d. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.45 sec. SDMT done. SDMT numerator: 49. SDMT denominator: 49. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:17.09 sec. 9-hole peg non-dominant:21.22 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Aubagio- Teriflunomide. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, cerebellar. Number of attacks until the first visit:4. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Visit diagnosis:rrms. Comments on DMT: Avonex, Mitoxantone, Rituximab. EDSS:0- normal neurological exam (all FS grade 0). Change in DMT or management done. Reason for DMT change:patient preference- convenience. New DMT:Imuran-Azathioprine. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Number of attacks until the first visit:5. OCBs in second CSF:positive. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on August 01, 2014. Comments on DMT: Avonex, betaferon. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.24 sec. 9-hole peg non-dominant:19.6 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:23.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.66. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on September 01, 2016. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: June 17, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 3.7 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.3 sec. 9-hole peg non-dominant:21.9 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:35.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. OCBs in CSF:positive. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:IBS . Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: Plegridy, Tecfidera. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.5 sec. 9-hole peg non-dominant:19 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Ocrevus - Ocrelizumab. The patient is in EDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:cellcept or imuxigen- mycophenolate on April 01, 2013. Comments on DMT: Avonex, Imuran. The 25-foot walk done. 25-foot walk test time was 4 sec. SDMT done. SDMT numerator: 45. SDMT denominator: 46. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15 sec. 9-hole peg non-dominant:17.1 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 29 months?",
        "output":"After 29 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:negative. Name of co-morbidity:T2 N0 M0, ER\/PR positive and HER-2 negative breast cancer. Outcome:ongoing illness. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteopenia. Outcome:ongoing illness. Visit diagnosis:spms. Total relapses until visit: 4. Comments on DMT: Gilenya, Aubagio, Tecfidera, Mabthera. Tobacco smoker: ex-smoker  The 25-foot walk done. Assistance required for 25-foot walk test: Cane. 25-foot walk test time was 55 sec. SDMT done. SDMT numerator: 44. SDMT denominator: 44. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.44 sec. 9-hole peg non-dominant:22.5 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:26.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:0.62. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tysabri- natalizumab on February 01, 2017. Comments on DMT: tecfidera. Tobacco smoker: non-smoker  Alcohol drinsk per week: 1. Vit D at visit: 50.5. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 57. SDMT denominator: 57. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.5 sec. 9-hole peg non-dominant:17.5 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 30 months?",
        "output":"After 30 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:5. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:tysabri- natalizumab on December 01, 2012. Comments on DMT: Avonex Sep 2010-Sep 2011, Betaferon Oct 2011-Feb 2012, Gilenya Mar 2010-Oct 2012. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.6 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.2 sec. 9-hole peg non-dominant:18.8 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:61.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.06. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Sciatica. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on May 01, 2015. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. No new lesions on Brain MRI. Evidence of LETM. The 25-foot walk done. 25-foot walk test time was 4.05 sec. SDMT done. SDMT numerator: 48. SDMT denominator: 50. 9-HPT done. 9-HPT ability: unable with the left hand. Dominant hand:Right.  9-hole peg dominant:16.24 sec. The patient is in EDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:rrms. Total relapses until visit: 1. There were new relapses since the previous visit. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2014. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: January 14, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. The 25-foot walk done. 25-foot walk test time was 3.86 sec. SDMT done. SDMT numerator: 64. SDMT denominator: 65. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:18.75 sec. 9-hole peg non-dominant:21.52 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:41.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness, optic neuritis. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on July 01, 2003. Vit D at visit: 92.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 3.48 sec. SDMT done. SDMT numerator: 66. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.59 sec. 9-hole peg non-dominant:16.72 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 10 months?",
        "output":"After 10 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation cerebellar. Number of attacks until the first visit:2. OCBs in CSF:negative. Name of co-morbidity:Migraine. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on August 24, 2016. Vit D at visit: 20.6. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Severe (more than 15 demyelinating lesions). Cervical spine MRI date: July 15, 2016. Received Gadolinium for Cervical spine MRI. Cervical spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in Cervical spine: 1. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.3 sec. SDMT done. SDMT numerator: 61. SDMT denominator: 61. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.32 sec. 9-hole peg non-dominant:22.05 sec. EDSS:2.5- minimal disability in two FS (two FS grade 2 others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:ocrevus - ocrelizumab on January 22, 2020. Comments on DMT: gilenya, rebif. Tobacco smoker: ex-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: July 17, 2020. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. Assistance required for 25-foot walk test: AFO. 25-foot walk test time was 5.1 sec. SDMT done. SDMT numerator: 41. SDMT denominator: 41. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.5 sec. 9-hole peg non-dominant:20 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 7 months?",
        "output":"After 7 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem. Number of attacks until the first visit:1. IgG index in CSF:0.82. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. There were new relapses since the previous visit. DMT taken. Current DMT:gilenya- fingolimod on September 25, 2014. Comments on DMT: Avonex. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 3. Total T1 Gad-enhancing lesions in Brain: 1. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: November 23, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: No lesions. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 109. SDMT denominator: 110. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.39 sec. 9-hole peg non-dominant:25.81 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). Change in DMT or management done. Reason for DMT change:clinical failure (loss of NEDA status). New DMT:Tecfidera-Dimethylfumarate. The patient is in EDA due to ALL: relapse, new MRI lesion, and EDSS change. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.6. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on March 01, 2018. Tobacco smoker: current  Tobacco type: cigarette or cigar. SDMT done. SDMT numerator: 72. SDMT denominator: 72. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:15.09 sec. 9-hole peg non-dominant:19.3 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:60.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation sensory, cerebellar. Has experienced progressive symptoms since onset. OCBs in CSF:positive. OCBs in second CSF:positive. IgG index in second:0.62. IgG index category in second CSF:Normal (< 0.77). Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Name of co-morbidity:Hyperthyroidism. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on July 01, 2019. Vit D at visit: 72.2. The 25-foot walk done. SDMT done. SDMT numerator: 45. SDMT denominator: 45. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:46 sec. 9-hole peg non-dominant:19.98 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 12 months?",
        "output":"After 12 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:74.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:2. OCBs in CSF:positive. Name of co-morbidity:Osteoporosis or osteopenia. More information on co-morbidity:Osteoporosis or osteopenia. Outcome:ongoing illness. Name of co-morbidity:Diabetes mellitus type 2. Outcome:ongoing illness. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:Gastrointestinal. Outcome:completely recovered from illness. Name of co-morbidity:Upper respiratory tract infection. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Surgeries. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:hip replacement surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:mabthera- rituximab on April 01, 2013. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: 2PPD. Coffee cups per week: 14. Vit D at visit: 36.5. MRI of brain or spine done. Cervical spine MRI date: November 16, 2017. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: Not compared to previous spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 12.8 sec. SDMT done. SDMT numerator: 9. SDMT denominator: 16. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.3 sec. 9-hole peg non-dominant:25.5 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:36.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.47. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:plegridy (peginterferon beta 1-a) on February 01, 2020. MRI of brain or spine done. No new lesions on Brain MRI. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: May 18, 2021. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.5 sec. SDMT done. SDMT numerator: 51. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.4 sec. 9-hole peg non-dominant:21.8 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:30.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, optic neuritis. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.22. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on November 07, 2016. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:42.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Number of attacks until the first visit:10. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:epilepsy. Outcome:ongoing illness. Visit diagnosis:rrms. Several relapses until this visit. DMT taken. Current DMT:gilenya- fingolimod on December 21, 2011. Comments on DMT: Avonex 2008-2011. Tobacco smoker: non-smoker  MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 4.55 sec. SDMT done. SDMT numerator: 56. SDMT denominator: 56. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.66 sec. 9-hole peg non-dominant:25.69 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:cis. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:1. OCBs in CSF:positive. IgG index in CSF:1.31. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Adenoidectomy. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Bartholin gland excision . Outcome:completely recovered from illness. Visit diagnosis:cis. Total relapses until visit: 1. Tobacco smoker: non-smoker  Vit D at visit: 18.0. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Mild (1 to 5 demyelinating lesions). Cervical spine MRI date: April 01, 2021. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 1. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 1. Whole spinal cord lesion load on MRI: Mild (1, 2, or 3 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 3.75 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.81 sec. 9-hole peg non-dominant:21 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 0 months?",
        "output":"After 0 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:29.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. OCBs in CSF:positive. Visit diagnosis:rrms. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on June 01, 2016. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. The 25-foot walk done. 25-foot walk test time was 5.24 sec. SDMT done. SDMT numerator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:21.5 sec. 9-hole peg non-dominant:19.6 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:43.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem, cerebellar. Number of attacks until the first visit:2. Name of co-morbidity:Gastrointestinal. More information on co-morbidity:ACID REFLUX . Outcome:ongoing illness. Visit diagnosis:cis. Total relapses until visit: 3. DMT taken. Current DMT:rebif or betaferon or recigen- sq interferon on February 01, 2013. Comments on DMT: Betaferon - Rebif. MRI of brain or spine done. The 25-foot walk done. 25-foot walk test time was 4.2 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:18.25 sec. 9-hole peg non-dominant:18.42 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 9 months?",
        "output":"After 9 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index category in CSF:High IgG index (> or = 0.77). Visit diagnosis:rrms. Total relapses until visit: 3. DMT taken. Current DMT:lemtrada- alemtuzumab on March 23, 2016. Comments on DMT: Betaferon. Tobacco smoker: current  Tobacco type: cigarette or cigar. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 1. Cervical spine MRI date: July 21, 2016. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in EDA due to new MRI lesions. Will the patient be in NEDA or EDA after 5 months?",
        "output":"After 5 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:47.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, brainstem, cerebellar. Number of attacks until the first visit:3. OCBs in CSF:positive. IgG index in CSF:1.54. Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Anemia. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:aubagio- teriflunomide on November 01, 2015. Comments on DMT: rebif, REFLEX trial, betafer. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: lighlt. Vit D at visit: 96.8. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 4.6 sec. SDMT done. SDMT numerator: 47. SDMT denominator: 48. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:20.51 sec. 9-hole peg non-dominant:24.81 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:side effects of current DMT. New DMT:Tecfidera-Dimethylfumarate. The patient is in NEDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:68.  Gender:male.  Diagnosis:rrms. Converted to SPMS.  Initial presentation sensory. Number of attacks until the first visit:3. Name of co-morbidity:Hypertension or cardiovascular. More information on co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. DMT taken. Current DMT: mabthera- rituximab. Comments on DMT: Rebif. The 25-foot walk done. 25-foot walk test time was 4.7 sec. SDMT done. SDMT numerator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:23.39 sec. 9-hole peg non-dominant:43.53 sec. EDSS:3- moderate disability in one FS (one FS grade 3 others 0 or 1) though fully ambulatory; or mild disability in three or four FS (three \/four FS grade 2 others 0 or 1) though fully ambulatory. The patient is in NEDA. Will the patient be in NEDA or EDA after 11 months?",
        "output":"After 11 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:60.  Gender:male.  Diagnosis:spms. Converted to SPMS.  Initial presentation motor weakness. Number of attacks until the first visit:2. Visit diagnosis:spms. The 25-foot walk done. 25-foot walk test time was 29.9 sec. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. The patient is in NEDA. Will the patient be in NEDA or EDA after 16 months?",
        "output":"After 16 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation optic neuritis. Number of attacks until the first visit:2. Visit diagnosis:nmo. Total relapses until visit: 1. DMT taken. Current DMT: mabthera- rituximab. Tobacco smoker: current  Tobacco type: cigarette or cigar. Tobacco type: water-pipe. The patient is in EDA. Will the patient be in NEDA or EDA after 13 months?",
        "output":"After 13 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:37.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:1.09. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Bipolar disorder. Total relapses until visit: 2. The 25-foot walk done. 25-foot walk test time was 4.5 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 51. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.81 sec. 9-hole peg non-dominant:19.31 sec. EDSS:1.5- no disability, minimal signs in more than one FS (more than one FS grade 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Gilenya- Fingolimod. The patient is in EDA. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:male.  Diagnosis:nmo. Has not converted to SPMS. Initial presentation sensory, motor weakness, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:nmo. Total relapses until visit: 2. DMT taken. Current DMT:mabthera- rituximab on July 01, 2022. Tobacco smoker: current  Tobacco type: cigarette or cigar. Coffee cups per week: 70. The 25-foot walk done. 25-foot walk test time was 6.2 sec. The patient is in NEDA. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:59.  Gender:female.  Diagnosis:ppms. Has not converted to SPMS. Initial presentation motor weakness. Has experienced progressive symptoms since onset. OCBs in CSF:positive. IgG index in CSF:0.97. IgG index category in CSF:High IgG index (> or = 0.77). Name of co-morbidity:Genito-urinary. More information on co-morbidity:UTI. Outcome:completely recovered from illness. Name of co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. More information on co-morbidity:disc disease. Outcome:ongoing illness. Visit diagnosis:ppms. DMT taken. Current DMT:mabthera- rituximab on May 18, 2018. Tobacco smoker: current  Tobacco type: water-pipe. MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 9.2 sec. EDSS:5- ambulatory without aid or rest for less than 200 meters (usual FS equivalents include at least one FS grade 5 or combinations of lesser grades usually exceeding specifications for step 4.5). The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 8 months?",
        "output":"After 8 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:40.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory, motor weakness. Number of attacks until the first visit:2. Visit diagnosis:rrms. DMT taken. Current DMT: rebif or betaferon or recigen- sq interferon. MRI of brain or spine done. Received Gadolinium for Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. The patient is in NEDA. Will the patient be in NEDA or EDA after 50 months?",
        "output":"After 50 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:63.  Gender:female.  Diagnosis:spms. Converted to SPMS.  Initial presentation optic neuritis. Number of attacks until the first visit:5. Visit diagnosis:spms. Total relapses until visit: 5. DMT taken. Current DMT:endoxan- cyclophosphamide on July 01, 2012. Comments on DMT: avonex, Rebif. Tobacco smoker: non-smoker  MRI of brain or spine done. No new lesions on Brain MRI. The 25-foot walk done. 25-foot walk test time was 12.2 sec. SDMT done. SDMT numerator: 50. SDMT denominator: 50. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Left.  9-hole peg dominant:19.92 sec. EDSS:5.5- ambulatory without aid or rest for \u00e2\u2030\u00a5100 meters. The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:44.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Visit diagnosis:rrms. Total relapses until visit: 4. DMT taken. Current DMT:mabthera- rituximab on November 01, 2018. Comments on DMT: Rebif. Vit D at visit: 38.4. MRI of brain or spine done. Received Gadolinium for Brain MRI. Presence of new lesions on Brain MRI. Number of new Brain T2 lesions: 1. Total T1 Gad-enhancing lesions in Brain: 0. Brain MRI lesion load: Moderate (6 to 15 demyelinating lesions). Cervical spine MRI date: April 17, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Thoracic spine MRI: T2 lesions, not gad-enhancing. Number of new T2 lesions in  Thoracic spine: 1. Total T1 Gad-enhancing lesions in Thoracic spine: 0. Whole spinal cord lesion load on MRI: Moderate  (4, 5 or 6 lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 4.73 sec. SDMT done. SDMT numerator: 54. SDMT denominator: 54. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:22.54 sec. 9-hole peg non-dominant:23.83 sec. EDSS:2- minimal disability in one FS (one FS grade 2, others 0 or 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:50.  Gender:female.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation sensory. Number of attacks until the first visit:2. OCBs in CSF:negative. IgG index in CSF:0.5. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Surgeries. More information on co-morbidity:Right breast nodule resection. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Lower back cyst resection. Outcome:completely recovered from illness. Name of co-morbidity:Surgeries. More information on co-morbidity:Laser surgery. Outcome:completely recovered from illness. Visit diagnosis:rrms. Total relapses until visit: 2. DMT taken. Current DMT:tecfidera-dimethylfumarate on April 01, 2017. Tobacco smoker: current  Tobacco type: water-pipe. The 25-foot walk done. 25-foot walk test time was 3.9 sec. SDMT done. SDMT numerator: 52. SDMT denominator: 52. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:16.3 sec. 9-hole peg non-dominant:21 sec. EDSS:1- no disability, minimal signs in one FS (one FS grade 1). The patient is in NEDA. Will the patient be in NEDA or EDA after 24 months?",
        "output":"After 24 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:54.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness, brainstem. Number of attacks until the first visit:6. OCBs in CSF:positive. IgG index in CSF:0.54. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Musculoskeletal. Outcome:ongoing illness. Visit diagnosis:spms. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: December 01, 2018. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Received Gadolinium for Thoracic (dorsal) spine MRI. Total T1 Gad-enhancing lesions in Thoracic spine: 0. The 25-foot walk done. 25-foot walk test time was 9.9 sec. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right. EDSS:6- unilateral assistance (cane or crutch) required to walk at least 100 meters with or without resting. Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). New DMT:Mabthera- Rituximab. The patient is in EDA due to Progression\/Worsening of MSFCs or FS scores. Will the patient be in NEDA or EDA after 4 months?",
        "output":"After 4 months the patient will be in EDA.",
        "label":"EDA"
    },
    {
        "text":"Age:28.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation motor weakness. Number of attacks until the first visit:1. IgG index in CSF:0.59. IgG index category in CSF:Normal (< 0.77). Visit diagnosis:rrms. Total relapses until visit: 1. DMT taken. Current DMT:gilenya- fingolimod on September 01, 2014. Comments on DMT: Avonex, Rebif. Tobacco smoker: non-smoker  The 25-foot walk done. 25-foot walk test time was 3.71 sec. SDMT done. SDMT numerator: 100. SDMT denominator: 100. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:19.6 sec. 9-hole peg non-dominant:23.6 sec. EDSS:0- normal neurological exam (all FS grade 0). The patient is in NEDA. Will the patient be in NEDA or EDA after 3 months?",
        "output":"After 3 months the patient will be in NEDA.",
        "label":"NEDA"
    },
    {
        "text":"Age:64.  Gender:male.  Diagnosis:rrms. Has not converted to SPMS. Initial presentation brainstem, bowel\/bladder dysfunction. Number of attacks until the first visit:2. OCBs in CSF:positive. IgG index in CSF:0.73. IgG index category in CSF:Normal (< 0.77). Name of co-morbidity:Dyslipidemia. More information on co-morbidity:Dyslipidemia. Outcome:ongoing illness.  Name of co-morbidity:Depression. More information on co-morbidity:Depression. Outcome:ongoing illness. Name of co-morbidity:Hypertension or cardiovascular. Outcome:ongoing illness. Visit diagnosis:rrms. Total relapses until visit: 2. Comments on DMT: gilenya, rebif. Tobacco smoker: ex-smoker  Alcohol drinsk per week: 1. Vit D at visit: 21.2. MRI of brain or spine done. Received Gadolinium for Brain MRI. No new lesions on Brain MRI. Total T1 Gad-enhancing lesions in Brain: 0. Cervical spine MRI date: April 03, 2019. Received Gadolinium for Cervical spine MRI. Total T1 Gad-enhancing lesions in Cervical spine: 0. Whole spinal cord lesion load on MRI: Severe (7 or more lesions in Cervical+Dorsal cord). The 25-foot walk done. 25-foot walk test time was 5.9 sec. SDMT done. SDMT numerator: 32. 9-HPT done. 9-HPT ability: yes, able with right and left hands. Dominant hand:Right.  9-hole peg dominant:34.7 sec. 9-hole peg non-dominant:19.9 sec. EDSS:3.5- fully ambulatory but with moderate disability in one FS (one FS grade 3) and mild disability in one or two FS (one\/two FS grade 2) and others 0 or 1; or fully ambulatory with two FS grade 3 (others 0 or 1);or fully ambulatory with five FS grade 2 (others 0 or 1). Change in DMT or management done. Reason for DMT change:Need to start a DMT (was off treatment). The patient is in EDA due to new EDSS or exam findings. Will the patient be in NEDA or EDA after 6 months?",
        "output":"After 6 months the patient will be in EDA.",
        "label":"EDA"
    }
]